Application

15601955 · BIOMARKER PROFILES FOR PREDICTING OUTCOMES OF CANCER THERAPY WITH ERBB3 INHIBITORS AND/OR CHEMOTHERAPIES

Filed 2017-05-22 · Granted · Patent 10273304 (2019-04-30) The official file ↗The patent and its PDF ↗ · Art unit 1642 · Examiner Nelson B Moseley II Easy · CPC C07K 16/2863 · Merrimack Pharmaceuticals, Inc. · NELSON MULLINS RILEY & SCARBOROUGH LLP/MERRIMACK

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

11.7 mo

to disposition 23.3 mo

Statutes raised

103 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.